{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T02:50:48Z","timestamp":1789181448321,"version":"build-2803163510"},"reference-count":112,"publisher":"Wiley","license":[{"start":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T00:00:00Z","timestamp":1653955200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Disease Markers"],"published-print":{"date-parts":[[2022,5,31]]},"abstract":"<jats:p>Since the first discovery of human immunodeficiency virus 1 (HIV-1) in 1983, the targeted treatment, antiretroviral therapy (ART), has effectively limited the detected plasma viremia below a very low level and the technique has been improved rapidly. However, due to the persistence of the latent reservoir of replication-competent HIV-1 in patients treated with ART, a sudden withdrawal of the drug inevitably results in HIV viral rebound and HIV progression. Therefore, more understanding of the HIV-1 latent reservoir (LR) is the priority before developing a cure that thoroughly eliminates the reservoir. HIV-1 spreads through both the release of cell-free particles and by cell-to-cell transmission. Mounting evidence indicates that cell-to-cell transmission is more efficient than cell-free transmission of particles and likely influences the pathogenesis of HIV-1 infection. This mode of viral transmission also influences the generation and maintenance of the latent reservoir, which represents the main obstacle for curing the infection. In this review, the definition, establishment, and maintenance of the HIV-1 LR, along with the state-of-the-art quantitative approaches that directly quantify HIV-1 intact proviruses, are elucidated. Strategies to cure HIV infection are highlighted. This review will renew hope for a better and more thorough cure of HIV infection for mankind and encourage more clinical trials to achieve ART-free HIV remission.<\/jats:p>","DOI":"10.1155\/2022\/6952286","type":"journal-article","created":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T20:06:20Z","timestamp":1654027580000},"page":"1-10","source":"Crossref","is-referenced-by-count":13,"title":["Insights into the HIV-1 Latent Reservoir and Strategies to Cure HIV-1 Infection"],"prefix":"10.1155","volume":"2022","author":[{"given":"Ruojing","family":"Bai","sequence":"first","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China"},{"name":"Beijing Key Laboratory for HIV\/AIDS Research, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiyun","family":"Lv","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China"},{"name":"Beijing Key Laboratory for HIV\/AIDS Research, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3083-2345","authenticated-orcid":true,"given":"Hao","family":"Wu","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3917-3027","authenticated-orcid":true,"given":"Lili","family":"Dai","sequence":"additional","affiliation":[{"name":"Center for Infectious Diseases, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","reference":[{"key":"1","article-title":"UNAIDS data","author":"UNAIDS","year":"2019"},{"key":"2","article-title":"Promise and progress of an HIV-1 cure by adeno-associated virus vector delivery of anti-HIV-1 biologics","volume":"10, article 176","author":"M. R. Gardner","year":"2020","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"issue":"5341","key":"3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1126\/science.278.5341.1291","article-title":"Recovery of replication-competent HIV despite prolonged suppression of plasma viremia","volume":"278","author":"J. K. Wong","year":"1997","journal-title":"Science"},{"key":"4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.53.082901.104024"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1038\/nm880"},{"issue":"430, article eaap 9927","key":"6","article-title":"HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing","volume":"10","author":"S. A. Yukl","year":"2018","journal-title":"Science Translational Medicine"},{"key":"7","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.78.17.9105-9114.2004"},{"key":"8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1007619"},{"key":"9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0033948"},{"key":"10","doi-asserted-by":"publisher","DOI":"10.1038\/nature13594"},{"issue":"11, article e1002417","key":"11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002417","article-title":"HIV-1 persistence following extremely early initiation of antiretroviral therapy (ART) during acute HIV-1 infection: an observational study","volume":"14","author":"T. J. Henrich","year":"2017","journal-title":"PLoS Medicine"},{"issue":"6510","key":"12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/373117a0","article-title":"Viral dynamics in human immunodeficiency virus type 1 infection","volume":"373","author":"X. Wei","year":"1995","journal-title":"Nature"},{"issue":"5","key":"13","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"D. Finzi","year":"1999","journal-title":"Nature Medicine"},{"key":"14","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav3491"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1097\/COH.0000000000000293"},{"key":"16","doi-asserted-by":"publisher","DOI":"10.1172\/JCI134815"},{"key":"17","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12732-2"},{"key":"18","doi-asserted-by":"publisher","DOI":"10.1038\/s41564-018-0335-z"},{"issue":"2, article e00337-19","key":"19","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00337-19","article-title":"Entry of polarized effector cells into quiescence forces HIV latency","volume":"10","author":"C. Dobrowolski","year":"2019","journal-title":"MBio"},{"issue":"7","key":"20","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/nm.4113","article-title":"PD-1+ and follicular helper T cells are responsible for persistent HIV-1 transcription in treated aviremic individuals","volume":"22","author":"R. Banga","year":"2016","journal-title":"Nature Medicine"},{"key":"21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1005349"},{"issue":"7, article e1005761","key":"22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005761","article-title":"CD4+ T cells expressing PD-1, TIGIT and LAG-3 contribute to HIV persistence during ART","volume":"12","author":"R. Fromentin","year":"2016","journal-title":"PLoS Pathogens"},{"issue":"11","key":"23","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1097\/QAD.0000000000001849","article-title":"PD-1 contributes to the establishment and maintenance of HIV-1 latency","volume":"32","author":"V. A. Evans","year":"2018","journal-title":"AIDS (London, England)"},{"key":"24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08798-7"},{"issue":"1","key":"25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-015-0204-2","article-title":"The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells","volume":"12","author":"N. A. Kumar","year":"2015","journal-title":"Retrovirology"},{"key":"26","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02225-17"},{"issue":"11","key":"27","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1038\/nm.2964","article-title":"SAMHD1 restricts HIV-1 infection in resting CD4+ T cells","volume":"18","author":"H. M. Baldauf","year":"2012","journal-title":"Nature Medicine"},{"issue":"9","key":"28","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/j.celrep.2016.02.022","article-title":"IL-7 induces SAMHD1 phosphorylation in CD4+ T lymphocytes, improving early steps of HIV-1 life cycle","volume":"14","author":"M. Coiras","year":"2016","journal-title":"Cell Reports"},{"issue":"7, article e1002818","key":"29","article-title":"Directly infected resting CD4+ T cells can produce HIV Gag without spreading infection in a model of HIV latency","volume":"8","author":"M. J. Pace","year":"2012","journal-title":"PLoS Pathogens"},{"key":"30","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1002894107"},{"issue":"6, article e1004955","key":"31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004955","article-title":"HIV latency is established directly and early in both resting and activated primary CD4 T cells","volume":"11","author":"L. Chavez","year":"2015","journal-title":"Plos Pathogens"},{"key":"32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2015.01.020"},{"issue":"3","key":"33","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1172\/JCI124291","article-title":"Intact HIV-1 proviruses accumulate at distinct chromosomal positions during prolonged antiretroviral therapy","volume":"129","author":"K. B. Einkauf","year":"2019","journal-title":"The Journal of Clinical Investigation"},{"key":"34","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08431-7"},{"key":"35","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1720665115"},{"key":"36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1600097113"},{"issue":"7, article e20200051","key":"37","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20200051","article-title":"Antigen-responsive CD4+ T cell clones contribute to the HIV-1 latent reservoir","volume":"217","author":"P. Mendoza","year":"2020","journal-title":"Journal of Experimental Medicine"},{"issue":"4","key":"38","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.20170193","article-title":"Proliferation of latently infected CD4+ T cells carrying replication-competent HIV-1: potential role in latent reservoir dynamics","volume":"214","author":"N. N. Hosmane","year":"2017","journal-title":"Journal of Experimental Medicine"},{"issue":"6193","key":"39","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1126\/science.1254194","article-title":"Specific HIV integration sites are linked to clonal expansion and persistence of infected cells","volume":"345","author":"F. Maldarelli","year":"2014","journal-title":"Science"},{"issue":"9","key":"40","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1128\/JVI.01617-15","article-title":"HIV integration site analysis of cellular models of HIV latency with a probe-enriched next-generation sequencing assay","volume":"90","author":"S. Sunshine","year":"2016","journal-title":"Journal of Virology"},{"key":"41","doi-asserted-by":"publisher","DOI":"10.1086\/527324"},{"issue":"11","key":"42","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1038\/nm.4411","article-title":"Defining total-body AIDS-virus burden with implications for curative strategies","volume":"23","author":"J. D. Estes","year":"2017","journal-title":"Nature Medicine"},{"key":"43","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2013.09.020"},{"issue":"6418","key":"44","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/362355a0","article-title":"HIV infection is active and progressive in lymphoid tissue during the clinically latent stage of disease","volume":"362","author":"G. Pantaleo","year":"1993","journal-title":"Nature"},{"key":"45","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.132997"},{"key":"46","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa634"},{"issue":"493, article aau0528","key":"47","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau0528","article-title":"Augmentation of HIV-specific T cell function by immediate treatment of hyperacute HIV-1 infection","volume":"11","author":"Z. M. Ndhlovu","year":"2019","journal-title":"Science Translational Medicine"},{"key":"48","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiy479"},{"issue":"3, article e1003211","key":"49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003211","article-title":"Post-treatment HIV-1 controllers with a long-term virological remission after the interruption of early initiated antiretroviral therapy ANRS VISCONTI study","volume":"9","author":"A. S\u00e1ez-Ciri\u00f3n","year":"2013","journal-title":"PLoS Pathogens"},{"issue":"513, article aaw5589","key":"50","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw5589","article-title":"The replication-competent HIV-1 latent reservoir is primarily established near the time of therapy initiation","volume":"11","author":"M. R. Abrahams","year":"2019","journal-title":"Science Translational Medicine"},{"key":"51","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.18889"},{"key":"52","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1027-4"},{"issue":"7","key":"53","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1056\/NEJMoa0802905","article-title":"Long-term control of HIV by CCR5 Delta32\/Delta32 stem-cell transplantation","volume":"360","author":"G. H\u00fctter","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"54","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S0092-8674(00)80110-5","article-title":"Homozygous defect in HIV-1 coreceptor accounts for resistance of some multiply-exposed individuals to HIV-1 infection","volume":"86","author":"R. Liu","year":"1996","journal-title":"Cell"},{"key":"55","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jbiotec.2018.08.007","article-title":"Strategies for controlling CRISPR\/Cas9 off-target effects and biological variations in mammalian genome editing experiments","volume":"284","author":"M. L. Kimberland","year":"2018","journal-title":"Journal of Biotechnology"},{"key":"56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1300662"},{"issue":"1","key":"57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12977-017-0375-0","article-title":"Genome modification of CXCR4 by Staphylococcus aureus Cas9 renders cells resistance to HIV-1 infection","volume":"14","author":"Q. Wang","year":"2017","journal-title":"Retrovirology"},{"key":"58","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0115987"},{"issue":"8","key":"59","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.ymthe.2017.04.027","article-title":"CRISPR\/Cas9-mediated CCR5 ablation in human hematopoietic stem\/progenitor cells confers HIV-1 resistance in vivo","volume":"25","author":"L. Xu","year":"2017","journal-title":"Molecular Therapy"},{"key":"60","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.omtn.2018.05.021","article-title":"Removal of HIV DNA by CRISPR from patient blood engrafts in humanized mice","volume":"12","author":"R. Bella","year":"2018","journal-title":"Molecular Therapy - Nucleic Acids"},{"key":"61","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.virusres.2018.04.002","article-title":"Genome scale screening identification of SaCas9\/gRNAs for targeting HIV-1 provirus and suppression of HIV-1 infection","volume":"250","author":"Q. Wang","year":"2018","journal-title":"Virus Research"},{"issue":"1, article 7784","key":"62","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26190-1","article-title":"CRISPR\/Cas9 system targeting regulatory genes of HIV-1 inhibits viral replication in infected T-cell cultures","volume":"8","author":"Y. Ophinni","year":"2018","journal-title":"Scientific Reports"},{"key":"63","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2016.24"},{"key":"64","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-10366-y"},{"key":"65","article-title":"Application of CRISPR\/Cas9-based gene editing in HIV-1\/AIDS therapy","volume":"9, article 69","author":"Q. Xiao","year":"2019","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"66","doi-asserted-by":"publisher","DOI":"10.1038\/487439a"},{"key":"67","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.01.014"},{"key":"68","doi-asserted-by":"publisher","DOI":"10.1016\/j.antiviral.2019.03.008"},{"key":"69","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.02625-15"},{"issue":"18","key":"70","doi-asserted-by":"crossref","first-page":"10803","DOI":"10.1128\/JVI.00320-14","article-title":"The histone deacetylase inhibitor vorinostat (SAHA) increases the susceptibility of uninfected CD4+ T cells to HIV by increasing the kinetics and efficiency of postentry viral events","volume":"88","author":"M. B. Lucera","year":"2014","journal-title":"Journal of Virology"},{"issue":"4, article e1004071","key":"71","article-title":"Histone deacetylase inhibitor romidepsin induces HIV expression in CD4 T cells from patients on suppressive antiretroviral therapy at concentrations achieved by clinical dosing","volume":"10","author":"D. G. Wei","year":"2014","journal-title":"PLoS Pathogens"},{"key":"72","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200209060-00006"},{"key":"73","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.168.6.3099"},{"issue":"1","key":"74","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12981-017-0177-4","article-title":"Eradication of HIV-1 latent reservoirs through therapeutic vaccination","volume":"14","author":"J. Pankrac","year":"2017","journal-title":"AIDS Research and Therapy"},{"key":"75","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.02166-16"},{"issue":"4","key":"76","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nm.3489","article-title":"New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo","volume":"20","author":"C. K. Bullen","year":"2014","journal-title":"Nature Medicine"},{"issue":"9, article e1005142","key":"77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005142","article-title":"The depsipeptide romidepsin reverses HIV-1 latency in vivo","volume":"11","author":"O. S. S\u00f8gaard","year":"2015","journal-title":"PLoS Pathogens"},{"key":"78","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1004278"},{"issue":"1","key":"79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms7838","article-title":"Manipulation of B-cell responses with histone deacetylase inhibitors","volume":"6","author":"M. Waibel","year":"2015","journal-title":"Nature Communications"},{"issue":"6193","key":"80","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1126\/science.1255512","article-title":"Immunologic strategies for HIV-1 remission and eradication","volume":"345","author":"D. H. Barouch","year":"2014","journal-title":"Science"},{"key":"81","doi-asserted-by":"publisher","DOI":"10.1186\/s12977-018-0451-0"},{"key":"82","doi-asserted-by":"publisher","DOI":"10.1128\/mBio.00465-15"},{"issue":"6","key":"83","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.chom.2016.11.001","article-title":"The mTOR complex controls HIV latency","volume":"20","author":"E. Besnard","year":"2016","journal-title":"Cell Host & Microbe"},{"key":"84","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(13)70343-8"},{"key":"85","doi-asserted-by":"publisher","DOI":"10.1038\/nature14053"},{"issue":"1","key":"86","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1089\/aid.2017.0071","article-title":"Immunogenicity of AGS-004 dendritic cell therapy in patients treated during acute HIV infection","volume":"34","author":"C. L. Gay","year":"2018","journal-title":"AIDS Research and Human Retroviruses"},{"issue":"3","key":"87","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/QAI.0000000000000852","article-title":"Immunization of HIV-1-infected persons with autologous dendritic cells transfected with mRNA encoding HIV-1 gag and nef: results of a randomized, placebo-controlled clinical trial","volume":"71","author":"R. T. Gandhi","year":"1999","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"88","article-title":"Continued decay of HIV proviral DNA upon vaccination with HIV-1 tat of subjects on long-term ART: an 8-year follow-up study","volume":"10, article 233","author":"C. Sgadari","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"89","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-018-0085-4"},{"issue":"6","key":"90","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.jinf.2017.09.004","article-title":"Sequential Vacc-4x and romidepsin during combination antiretroviral therapy (cART): immune responses to Vacc-4x regions on p 24 and changes in HIV reservoirs","volume":"75","author":"G. Tapia","year":"2017","journal-title":"Journal of Infection"},{"key":"91","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(16)30055-8"},{"issue":"21","key":"92","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1056\/NEJMoa1608243","article-title":"Effect of HIV antibody VRC01 on viral rebound after treatment interruption","volume":"375","author":"K. J. Bar","year":"2016","journal-title":"New England Journal of Medicine"},{"key":"93","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0531-2"},{"issue":"6288","key":"94","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1126\/science.aaf1279","article-title":"Enhanced clearance of HIV-1\u2013infected cells by broadly neutralizing antibodies against HIV-1 in vivo","volume":"352","author":"C. L. Lu","year":"2016","journal-title":"Science"},{"key":"95","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-019-0747-1"},{"issue":"1","key":"96","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1080\/22221751.2020.1713707","article-title":"Broadly neutralizing antibodies for HIV-1: efficacies, challenges and opportunities","volume":"9","author":"Y. Liu","year":"2020","journal-title":"Emerging Microbes & Infections"},{"issue":"1","key":"97","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/nrclinonc.2017.128","article-title":"Chimeric antigen receptor T-cell therapies for lymphoma","volume":"15","author":"J. N. Brudno","year":"2018","journal-title":"Nature Reviews Clinical Oncology"},{"key":"98","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4441"},{"issue":"9","key":"99","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1038\/s41591-019-0549-5","article-title":"Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR","volume":"25","author":"S. Ghorashian","year":"2019","journal-title":"Nature Medicine"},{"issue":"2","key":"100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/s11904-018-0388-x","article-title":"Quarter century of anti-HIV CAR T cells","volume":"15","author":"T. A. Wagner","year":"2018","journal-title":"Current HIV\/AIDS Reports"},{"key":"101","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2018.08.015"},{"issue":"3","key":"102","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.ymthe.2016.12.023","article-title":"Engineering HIV-resistant, anti-HIV chimeric antigen receptor T cells","volume":"25","author":"M. Hale","year":"2017","journal-title":"Molecular Therapy"},{"issue":"504, article aav5685","key":"103","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav5685","article-title":"Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model","volume":"11","author":"K. Anthony-Gonda","year":"2019","journal-title":"Science Translational Medicine"},{"issue":"2","key":"104","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nri.2017.112","article-title":"Immune checkpoint blockade in infectious diseases","volume":"18","author":"M. N. Wykes","year":"2018","journal-title":"Nature Reviews Immunology"},{"key":"105","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2017.09.018"},{"issue":"8","key":"106","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/nm.1972","article-title":"HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation","volume":"15","author":"N. Chomont","year":"2009","journal-title":"Nature Medicine"},{"key":"107","article-title":"Targeting immune checkpoint molecules to eliminate latent HIV","volume":"9, article 2339","author":"Z. Boyer","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"108","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jix191"},{"issue":"6","key":"109","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/COH.0000000000000324","article-title":"Therapeutic vaccines and immunological intervention in HIV infection: a paradigm change","volume":"11","author":"G. Pantaleo","year":"2016","journal-title":"Current Opinion in HIV and AIDS"},{"key":"110","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1901191"},{"key":"111","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(19)30052-9"},{"key":"112","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3018(15)00186-1"}],"container-title":["Disease Markers"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/downloads.hindawi.com\/journals\/dm\/2022\/6952286.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/dm\/2022\/6952286.xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/downloads.hindawi.com\/journals\/dm\/2022\/6952286.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T20:07:08Z","timestamp":1654027628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.hindawi.com\/journals\/dm\/2022\/6952286\/"}},"subtitle":[],"editor":[{"given":"Meng-Hao","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2022,5,31]]},"references-count":112,"alternative-id":["6952286","6952286"],"URL":"https:\/\/doi.org\/10.1155\/2022\/6952286","relation":{},"ISSN":["1875-8630","0278-0240"],"issn-type":[{"value":"1875-8630","type":"electronic"},{"value":"0278-0240","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5,31]]}}}